Management of rheumatic diseases in the time of covid-19 pandemic: perspectives of rheumatology practitioners from India

Ann Rheum Dis. 2021 Jan;80(1):e1. doi: 10.1136/annrheumdis-2020-217509. Epub 2020 Apr 16.

Authors

Latika Gupta¹, Durga Prasanna Misra¹, Vishwesh Agarwal², Suma Balan³, Vikas Agarwal⁴

Affiliations

¹ Clinical Immunology and Rheumatology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, UP, India.
² Mahatma Gandhi Mission's Medical College, Navi Mumbai, Maharashtra, India.
³ Department of Paediatric Rheumatology, Amrita Institute of Medical Sciences and Research Centre, Cochin, Kerala, India.
⁴ Clinical Immunology and Rheumatology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, UP, India [email protected].

PMID: 32299795
DOI: 10.1136/annrheumdis-2020-217509

No abstract available

Keywords: antirheumatic agents; autoimmune diseases; biological therapy; communicable diseases, imported; glucocorticoids.

Publication types

Letter
Comment

MeSH terms

Arthritis*
COVID-19*
Humans
India / epidemiology
Pandemics
Rheumatic Diseases* / epidemiology
Rheumatology*
SARS-CoV-2